#NICE #JnJ #Haematology #multiplemyeloma #daratumumab #daratumumabquadruplet #transplanteligiblemyeloma #NICEGuidance #MRDguidedtreatment #NICEFinalDraftGuidance #PERSEUSdata #daratumumabbasedregimen #VRdinduction #MRDguidedapproach #personalisedtreatment #PatientAccess
zurl.co/ZmXyU